Fanaptum iloperidone tablets

Swiss trademark · 696837 · Combined mark · In force

Register entry

Registration number
696837
Application number
63409/2016
Status
In force
Type
Combined mark
As registered
Fanaptum iloperidone tablets ((fig.))
Filed
Nov 2, 2016
Registered
Dec 21, 2016
Published
Dec 21, 2016
Protected until
Nov 2, 2036
Language of procedure
German
Vienna classes
27.05.01
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate; pharmazeutische Präparate und Substanzen zur Verwendung für die Behandlung des Zentralnervensystems; pharmazeutische Präparate und Substanzen zur Verwendung für die Behandlung von psychotischen Störungen; pharmazeutische Präparate und Substanzen zur Verwendung für die Behandlung von Schizophrenie, Depressionen und bipolaren Störungen; pharmazeutische Präparate mit dem Wirkstoff Iloperidon.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 12, 2026

    Renewed

    Expiry date
    02.11.2026 → 02.11.2036

    Published in Swissreg on 12.06.2026

  2. Dec 21, 2016

    Registered

    Published in Swissreg on 21.12.2016

Parties

Holder

Vanda Pharmaceuticals Inc.

2200 Pennsylvania Ave NW Suite 300E, Washington, DC 20037, US

Agent

Meisser & Partners AG

Schulstrasse 1, 7302 Landquart

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.